Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2022-12-06

FDA Approved: CALDOLOR — Supplemental Application (Cumberland Pharmaceuticals Inc.)

View source ↗

Summary

FDA action on a Cumberland Pharmaceuticals supplemental application for CALDOLOR (ibuprofen) to modify the product label. The action concerns labeling changes f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CALDOLOR (Ibuprofen)

Snippet

SUPPL AP for CALDOLOR (IBUPROFEN)